Skip to content

Motivational Interviewing to Increase PrEP Uptake (MI-PrEP)

Motivational Interviewing to Increase PrEP Uptake (MI-PrEP)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03592719
Acronym
MI-PrEP
Enrollment
50
Registered
2018-07-19
Start date
2018-10-01
Completion date
2019-11-11
Last updated
2020-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Risk Factor

Keywords

HIV Prevention, PrEP, Black, African American, Women, Motivational Interviewing, At risk for HIV

Brief summary

The purpose of this study is to test a counseling program for Black women at high risk for HIV

Interventions

BEHAVIORALExperimental Intervention (MI-PrEP)

The experimental intervention will consist of two sessions. The first session will involve psycho-education on PrEP and Motivational Interviewing to explore ambivalence about PrEP uptake. The second session will involve Motivational Interviewing and case management to explore barriers to accessing PrEP.

Participants assigned to the control condition will receive two sessions, both of which involve psychoeducation on PrEP.

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* HIV-negative * Identify as Black and/or African American * Age 18 or older * Cis-gender Female * English speaking * Is capable of completing and fully understanding the informed consent process and the study procedures and * Meets the Center for Disease Control's indications for PrEP use (17): (a) any sex with opposite sex partners in the past 6 months and (b) not in a monogamous partnership with a recently tested HIV-negative partner or (c) any injection of drugs not prescribed by a clinician in the past 6 months AND (d) at least one of the following: (i) infrequently uses condoms in sex with one/more partners of unknown HIV status (ii) in a sexual relationship with an HIV-positive partner or (iii) any sharing of injection/drug preparation equipment in past 6 months.

Exclusion criteria

* Not capable of completing/fully understanding the consent process and the study procedures.

Design outcomes

Primary

MeasureTime frameDescription
Change in Motivation for PrEPBaseline, Up to 6 weeksMotivation to use PrEP will be measured with the Contemplation Ladder and the Readiness Ruler, which assess intention to use PrEP and the perceived importance of using PrEP. The Contemplation Ladder and the Readiness Ruler each have a total score range from 0 to 10. Higher scores on the Contemplation Ladder indicate higher levels of contemplation or consideration about PrEP use. Higher scores on the Readiness Ruler indicate higher perceived importance of starting PrEP.
Change in PrEP uptakeBaseline, Up to 6 weeksPrEP uptake will be verified by the participants' providers.

Secondary

MeasureTime frameDescription
Change in Knowledge of PrEPBaseline, Up to 6 weeksKnowledge of PrEP will be measured using a PrEP fact sheet, with basic information about PrEP. The PrEP Fact Sheet has a total score range of 0 to 12, with higher scores indicating higher levels of PrEP knowledge.
Change in Barriers for PrEPBaseline, Up to 6 weeksPerceived barriers to PrEP uptake/usage will be measured by an adapted version of the Barriers to Care Scale, in which participants are asked about factors that make it difficult to receive PrEP related services. The Barriers to Care scale has a total score range of 7 to 28, with higher scores indicating increased difficulty regarding barriers to PrEP uptake.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026